hsa-mir-937: Hsa-mir-937 is a microRNA that has been identified as a potential regulator of COL1A2, LEP, and SERPINE1, and further investigation is needed to confirm this [PMC7646902]. The expression levels of hsa-mir-937, hsa-miR-148b*, hsa-miR-3907, and hsa-miR-367* were validated using RT-qPCR and were found to be significantly decreased in patients with EOPE compared to the control group [PMC7646902]. Additionally, the expression levels of COL1A2, LEP, and SERPINE1 were significantly increased in the EOPE group [PMC7646902]. The expression changes of hsa-mir-937, hsa-miR-148b*, hsa-miR-3907, hsa-miR-367*, COL1A2, LEP, and SERPINE1 were also validated in the placenta of patients with PE compared to controls [PMC7646902]. Specific primers for amplifying hsa-mir-937 were listed in Table III [PMC7646902]. Furthermore, miR-937 was found to be significantly downregulated in patients with chronic obstructive pulmonary disease (COPD) compared to healthy controls [PMC8231861]. In cervical squamous cell carcinoma (CESC), miR-937 was identified as one of the miRNAs associated with poor overall survival [PMC7333649]. The prognostic value of miRNAs including miR-937 was evaluated using the Kaplan-Meier Plotter database [PMC7333649]. In a study on asthma patients exposed to diesel exhaust particles (DEP), miRNA profiling revealed altered blood expression levels of several miRNAs including miR-937 [PMC4786978]. Additionally, in autism spectrum disorder (ASD), miR-937 was found to be downregulated [PMC9000903].